Is numbness and tingling a side effect of losartan?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Numbness and Tingling Are Not Listed as Side Effects of Losartan

Numbness and tingling are not documented as side effects of losartan in the FDA drug label or major clinical trials. The FDA-approved prescribing information for losartan does not include paresthesia (numbness/tingling) among its adverse reactions 1.

Documented Side Effects of Losartan

The most common side effects of losartan in hypertensive patients include 1:

  • Upper respiratory infection (8%)
  • Dizziness (3%)
  • Stuffy nose (2%)
  • Back pain (2%)

In patients with type 2 diabetes and diabetic kidney disease, the most common side effects are 1:

  • Diarrhea
  • Tiredness
  • Low blood sugar
  • Chest pain
  • High blood potassium
  • Low blood pressure

Important Distinction: Diabetic Neuropathy vs. Drug Side Effect

If you are experiencing numbness and tingling while taking losartan, this is much more likely related to diabetic peripheral neuropathy rather than the medication itself. Diabetic peripheral neuropathy commonly causes burning, tingling, and numbness, particularly in patients with type 2 diabetes 2, 3.

Key Clinical Features of Diabetic Neuropathy:

  • Small-fiber involvement causes pain and dysesthesia (burning and tingling sensations) 2, 3
  • Large-fiber involvement causes numbness and loss of protective sensation 2, 3
  • Up to 50% of diabetic peripheral neuropathy may be asymptomatic initially 2

Clinical Safety Profile

Large-scale clinical trials demonstrate losartan's excellent tolerability 4, 5:

  • In approximately 3,800 patients across 16 double-masked trials, only dizziness occurred more frequently (≥1%) with losartan versus placebo 4
  • Discontinuation rates due to adverse events were actually lower with losartan (2.3%) compared to placebo (3.7%) 5
  • A community-based study found losartan better tolerated than ACE inhibitors and calcium channel blockers 6

Rare Neurological Case Report

There is one isolated case report from 2019 describing tremors and dysarthria (not numbness/tingling) associated with losartan use 7. However, this represents an extremely rare occurrence and involved different neurological symptoms than what you're asking about.

Clinical Recommendation

If you are experiencing numbness and tingling while on losartan, you should be evaluated for diabetic peripheral neuropathy rather than attributing these symptoms to the medication. Annual screening for diabetic peripheral neuropathy is recommended for all patients with type 2 diabetes using pinprick sensation, temperature sensation, vibration perception with a 128-Hz tuning fork, and 10-g monofilament testing 2, 3.

The treatment for diabetic neuropathy focuses on optimizing glucose control and may include medications like pregabalin or duloxetine for neuropathic pain 8, 3, not discontinuation of losartan, which provides important cardiovascular and renal protection in diabetic patients 9, 10.

References

Research

Clinical safety and tolerability of losartan.

Clinical therapeutics, 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.